Cancer stem cells and chemosensitivity

Marcello Maugeri-Saccà, Paolo Vigneri, Ruggero De Maria

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Cancer lethality is mainly due to the onset of distant metastases and refractoriness to chemotherapy. Thus, the development of molecular targeted agents that can restore or increase chemosensitivity will provide valuable therapeutic options for cancer patients. Growing evidence indicates that a cellular subpopulation with stem cell-like features, commonly referred to as cancer stem cells (CSCs), is critical for tumor generation and maintenance. Recent advances in stem cell biology are revealing that this cellular fraction shares many properties with normal adult stem cells and is able to propagate the parental tumor in animal models. CSCs seem to be protected against widely used chemotherapeutic agents by means of different mechanisms, such as a marked proficiency in DNA damage repair, high expression of ATP-binding cassette drug transporters, and activation of PI3K/AKT and Wnt pathways. Moreover, microenvironmental stimuli such as those involved in the epithelial-mesenchymal transition and hypoxia indirectly contribute to chemoresistance by inducing in cancer cells a stem-like phenotype. Understanding how CSCs overcome chemotherapy-induced death stimuli, and integrating such knowledge into clinical research methodology, has become a priority in the process of identifying innovative therapeutic strategies aimed at improving the outcome of cancer patients.

Original languageEnglish
Pages (from-to)4942-4947
Number of pages6
JournalClinical Cancer Research
Volume17
Issue number15
DOIs
Publication statusPublished - Aug 1 2011

Fingerprint

Neoplastic Stem Cells
Neoplasms
Stem Cells
Drug Therapy
Wnt Signaling Pathway
Adult Stem Cells
Epithelial-Mesenchymal Transition
ATP-Binding Cassette Transporters
Phosphatidylinositol 3-Kinases
DNA Repair
DNA Damage
Cell Biology
Research Design
Animal Models
Maintenance
Neoplasm Metastasis
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cancer stem cells and chemosensitivity. / Maugeri-Saccà, Marcello; Vigneri, Paolo; De Maria, Ruggero.

In: Clinical Cancer Research, Vol. 17, No. 15, 01.08.2011, p. 4942-4947.

Research output: Contribution to journalArticle

Maugeri-Saccà, Marcello ; Vigneri, Paolo ; De Maria, Ruggero. / Cancer stem cells and chemosensitivity. In: Clinical Cancer Research. 2011 ; Vol. 17, No. 15. pp. 4942-4947.
@article{6059ecd5d0554e14b94a7bf78dcb654b,
title = "Cancer stem cells and chemosensitivity",
abstract = "Cancer lethality is mainly due to the onset of distant metastases and refractoriness to chemotherapy. Thus, the development of molecular targeted agents that can restore or increase chemosensitivity will provide valuable therapeutic options for cancer patients. Growing evidence indicates that a cellular subpopulation with stem cell-like features, commonly referred to as cancer stem cells (CSCs), is critical for tumor generation and maintenance. Recent advances in stem cell biology are revealing that this cellular fraction shares many properties with normal adult stem cells and is able to propagate the parental tumor in animal models. CSCs seem to be protected against widely used chemotherapeutic agents by means of different mechanisms, such as a marked proficiency in DNA damage repair, high expression of ATP-binding cassette drug transporters, and activation of PI3K/AKT and Wnt pathways. Moreover, microenvironmental stimuli such as those involved in the epithelial-mesenchymal transition and hypoxia indirectly contribute to chemoresistance by inducing in cancer cells a stem-like phenotype. Understanding how CSCs overcome chemotherapy-induced death stimuli, and integrating such knowledge into clinical research methodology, has become a priority in the process of identifying innovative therapeutic strategies aimed at improving the outcome of cancer patients.",
author = "Marcello Maugeri-Sacc{\`a} and Paolo Vigneri and {De Maria}, Ruggero",
year = "2011",
month = "8",
day = "1",
doi = "10.1158/1078-0432.CCR-10-2538",
language = "English",
volume = "17",
pages = "4942--4947",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Cancer stem cells and chemosensitivity

AU - Maugeri-Saccà, Marcello

AU - Vigneri, Paolo

AU - De Maria, Ruggero

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Cancer lethality is mainly due to the onset of distant metastases and refractoriness to chemotherapy. Thus, the development of molecular targeted agents that can restore or increase chemosensitivity will provide valuable therapeutic options for cancer patients. Growing evidence indicates that a cellular subpopulation with stem cell-like features, commonly referred to as cancer stem cells (CSCs), is critical for tumor generation and maintenance. Recent advances in stem cell biology are revealing that this cellular fraction shares many properties with normal adult stem cells and is able to propagate the parental tumor in animal models. CSCs seem to be protected against widely used chemotherapeutic agents by means of different mechanisms, such as a marked proficiency in DNA damage repair, high expression of ATP-binding cassette drug transporters, and activation of PI3K/AKT and Wnt pathways. Moreover, microenvironmental stimuli such as those involved in the epithelial-mesenchymal transition and hypoxia indirectly contribute to chemoresistance by inducing in cancer cells a stem-like phenotype. Understanding how CSCs overcome chemotherapy-induced death stimuli, and integrating such knowledge into clinical research methodology, has become a priority in the process of identifying innovative therapeutic strategies aimed at improving the outcome of cancer patients.

AB - Cancer lethality is mainly due to the onset of distant metastases and refractoriness to chemotherapy. Thus, the development of molecular targeted agents that can restore or increase chemosensitivity will provide valuable therapeutic options for cancer patients. Growing evidence indicates that a cellular subpopulation with stem cell-like features, commonly referred to as cancer stem cells (CSCs), is critical for tumor generation and maintenance. Recent advances in stem cell biology are revealing that this cellular fraction shares many properties with normal adult stem cells and is able to propagate the parental tumor in animal models. CSCs seem to be protected against widely used chemotherapeutic agents by means of different mechanisms, such as a marked proficiency in DNA damage repair, high expression of ATP-binding cassette drug transporters, and activation of PI3K/AKT and Wnt pathways. Moreover, microenvironmental stimuli such as those involved in the epithelial-mesenchymal transition and hypoxia indirectly contribute to chemoresistance by inducing in cancer cells a stem-like phenotype. Understanding how CSCs overcome chemotherapy-induced death stimuli, and integrating such knowledge into clinical research methodology, has become a priority in the process of identifying innovative therapeutic strategies aimed at improving the outcome of cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=79960976034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960976034&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-10-2538

DO - 10.1158/1078-0432.CCR-10-2538

M3 - Article

C2 - 21622723

AN - SCOPUS:79960976034

VL - 17

SP - 4942

EP - 4947

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 15

ER -